on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has released its Form 8.3 concerning its interests in Mural Oncology plc. As of August 18, 2025, Vanguard held 771,747 ordinary shares in Mural Oncology, representing a 4.47% stake. This disclosure aligns with Rule 8.3 of the Irish Takeover Panel Act, 1997, and Takeover Rules, 2022.
The document specifies that Vanguard sold 48 of these shares at $1.82 each. No cash-settled or stock-settled derivatives were listed in the form. The report indicates there are no agreements or commitments influencing the deal's outcome. Notably, there are also no attachments or supplemental forms included in the disclosure.
This statement provides important transparency for stakeholders regarding Vanguard's position in Mural Oncology amid potential takeover discussions.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news